2024 Invited and Confirmed Panelists
- Michael Aberman, MD, General Partner, Regeneron Ventures
- Peter Alff, PhD, Venture Partner, Orange Grove Bio
- Troy André, PhD, SVP, Business Innovation, Lead, Commercial Strategy & Innovation, Pfizer, Inc.
- Marc Appel, JD, MBA, Entrepreneur In Residence, Yale Ventures
- Michael Baran, PhD, MBA, Partner, Pfizer Ventures, Executive Director, External Science & Innovation, Worldwide R&D, Pfizer, Inc.
- Dawn Bell, PharmD, CEO, Antlia Bioscience, Founder & Director, Myracle Therapeutics, Board Member, NewYorkBIO
- Michael R. Bielski, MS, Founder & President, DevTech Partners
- Lazar Bojic, PhD, Head, Investor Network, Curie.Bio
- Ava Bousher, DVM, PharmD, Global Access Strategy & Pricing, Senior Director, Oncology GU Pipeline & BD Lead, Pfizer
- Scott P. Bruder, MD, PhD, Founder & CEO, Bruder Consulting & Venture Group
- Brian Busser, PhD, Founder & SVP, R&D, Enceladus Bio
- Adrian Charbin, PhD, Executive Director, Solid Tumor Strategy, Novartis
- Eva Chmielnicki, PhD, Senior Director, Business Development, Bristol Myers Squibb
- Pavan Choksi, Partner, Arkitekt Ventures
- Silvia Garcia Codony, MBA, MSc, Assistant Vice President, NY Ventures, Empire State Development
- J. Robert Coleman, PhD, CEO, Hervolution
- Alexander Dundara, CPA, MBA, Partner, Life Sciences, Technology & Emerging Growth, Withum
- Diane Fabel, PhD, Director, Operations, Center for Biotechnology
- Jonathan Fassberg, MBA, Managing Partner, Astr Partners
- Christine Fischette, PhD, CEO, BioLinkUp
- Sherry Grisewood, CFA, Senior Investment Officer, FoxHill Asset Management
- Jiaping Gu, PhD, Investment Director & Partner, Takeda Ventures
- Gaurav Gupta, MD, MSE, Co-Managing Partner, Life Science Private Capital, J.P. Morgan Private Capital
- John Gustofson, MS, MBA, Head, Chugai Venture Fund
- Harold Hess, Partner, EisnerAmper LLP
- Poorya Hosseini, Partner, Camford Capital
- Chun Hu, PhD, Associate, Canaan Partners
- Matthew R. Kittay, MBA, Partner, Co-Chair of Mergers & Acquisitions, Fox Rothschild LLP
- Ben Kromnick, Head of Healthcare and Life Sciences, Mercury
- Orly Levitan, PhD, VP, Partnerships and Business Development, Pragma Bio
- Sanford J. Madigan, PhD, Managing Partner, Avalon BioVentures
- Jonathan Mandelbaum, PhD, Vice President, OrbiMed
- Bridget Martell, MD, MA, Operating Partner, Biotechnology, Two Bear Capital
- Megan McGill, MD, PhD, CEO, Epitor Therapeutics
- Rachel Mears, Partner, Jeito Capital
- Lawrence Monoson, MSc, Co-Founder, RxData, Inc.
- Remo Moomiaie-Qajar, MD, Founder and CEO, Cytonus Therapeutics
- Marian Nakada, PhD, VP, Venture Investments, Johnson & Johnson Innovation – JJDC
- Saikat Nandi, PhD, MS, Founder & Managing Partner, Gene Allele Capital
- Michael Norsen, MBA, Vice President, Alexandria Venture Investments & Head, LaunchLabs-NYC
- Sandra Pérez Baos, PhD, Associate, 2048 Ventures
- Maria Luisa Pineda, PhD, CEO, Envisagenics
- John Prufeta, General Partner, Medical Excellence Capital, LLC
- Clinton T. Rubin, PhD, Director, Center for Biotechnology
- Uciane Scarlett, PhD, Principal, MPM Capital
- Ryan Schipke, Director, Johnson & Johnson – Innovative Medicine, Business Development
- Joel Sendek, Managing Director, Head of Healthcare Life Sciences Research, Oppenheimer & Co. Inc.
- Gaurav Shah, MD, CEO, Rocket Pharma
- Nimish Shah, MBA, MPH, Partner, Venrock
- David Shin, MD, Venture Partner, BioAdvance
- Nadim Shohdy, PhD, VP, Corporate Development, Hyku Bioscience
- Yaniv Sneor, Co-Founder, Mid Atlantic Bio Angels; CEO, Native State Therapeutics
- Isaac Stoner, MBA, Director, Co-Founder & CEO, Octagon Therapeutics
- R. Nolan Townsend, MBA, CEO, Lexeo Therapeutics
- Gerardo Ubaghs, CFO, Frontier Medicines
- Pete Vaccaro, Partner, Formulary Insights
- Xinchen Wang, PhD, Co-Founder & CEO, Waypoint Bio
- Anton Xavier, MBA, Director, Startup Banking Life Sciences, SVB Financial Group
- Adam Yaari, PhD, Co-Founder & CEO, Serinus.Bio
- Cookie Yu, PhD, Investment Director, Samsung Ventures
- Alex Zisson, Managing Director, H.I.G. Capital